Drug development and acute gastrointestinal infections

Expert Opinion on Investigational Drugs

Volumn 27, Issue 3, 2018, Pages 219-224

  Szajewska, Hania ^a   Kołodziej, Maciej ^a   Łukasik, Jan ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antidiarrheal drugs; diarrhea; oral rehydration; treatment

Indexed keywords

FAT; GASTROINTESTINAL AGENT; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; OLIGOSACCHARIDE; ORAL REHYDRATION SOLUTION; POLYPHENOL;

ACUTE GASTROENTERITIS; BACTERIOPHAGE; BREAST MILK; CLINICAL TRIAL (TOPIC); EDITORIAL; HUMAN; MICROFLORA; NONHUMAN; ACUTE DISEASE; DIARRHEA; DRUG DESIGN; GASTROINTESTINAL DISEASE; INFECTION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACUTE DISEASE; CHILD, PRESCHOOL; DIARRHEA; DRUG DESIGN; GASTROINTESTINAL DISEASES; HUMANS; INFECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85039045090     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1080/13543784.2018.1420779     Document Type: Editorial

References (25)

1. Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014;59:132–152.
2. Parashar UD, Johnson H, Steele AD, et al. Health impact of rotavirus vaccination in developing countries: progress and way forward. Clin Infect Dis. 2016;62(Suppl 2):S91–S95.
3. Alam NH, Ashraf H, Kamruzzaman M, et al. Efficacy of partially hydrolyzed guar gum (PHGG) supplemented modified oral rehydration solution in the treatment of severely malnourished children with watery diarrhoea: a randomised double-blind controlled trial. J Health Popul Nutr. 2015;34:3.
4. Thiagarajah JR, Ko EA, Tradtrantip L, et al. Discovery and development of antisecretory drugs for treating diarrheal diseases. Clin Gastroenterol Hepatol. 2014;12:204–209.
5. Thiagarajah JR, Donowitz M, Verkman AS., Secretory diarrhoea: mechanisms and emerging therapies. Nat Rev Gastroenterol Hepatol. 2015;12:446–457.
6. Donowitz M, Alpers DH, Binder HJ, et al. Translational approaches for pharmacotherapy development for acute diarrhea. Gastroenterology. 2012;142:e1–e9.
7. Zaman S, Aamir K, Lange S, et al. Antisecretory factor effectively and safely stops childhood diarrhoea: a placebo-controlled, randomised study. Acta Paediatr. 2014 Jun;103(6):659–664.
8. Macarthur RD, Hawkins TN, Brown SJ, et al. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study. HIV Clin Trials. 2013;14:261–273.
9. Franceschi F, Scaldaferri F, Riccioni ME, et al. Management of acute diarrhea: current and future trends. Eur Rev Med Pharmacol Sci. 2014;18:2065–2069.
10. Çağan E, Ceylan S, Mengi Ş, et al. Evaluation of gelatin tannate against symptoms of acute diarrhea in pediatric patients. Med Sci Monit. 2017;23:2029–2034.
11. Michałek D, Kołodziej M, Konarska Z, et al. Efficacy and safety of gelatine tannate for the treatment of acute gastroenteritis in children: protocol of a randomised controlled trial. BMJ Open. 2016;6:e010530.
12. Gnessi L, Bacarea V, Marusteri M, et al. Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial. BMC Gastroenterol. 2015;15:153.
13. Pleșea Condratovici C, Bacarea V, Piqué N., Xyloglucan for the treatment of acute gastroenteritis in children: results of a randomized, controlled, clinical trial. Gastroenterol Res Pract. 2016;2016:6874207.
14. Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011;1:111–114.
15. Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 2016;4:124–137.
16. Kunz C, Meyer C, Collado MC, et al. Influence of gestational age, secretor, and Lewis blood group status on the oligosaccharide content of human milk. J Pediatr Gastroenterol Nutr. 2017;64:789–798.
17. Hamosh M, Peterson JA, Henderson TR, et al. Protective function of human milk: the milk fat globule. Semin Perinatol. 1999;23:242–249.
18. Bruggencate SJ, Frederiksen PD, Pedersen SM, et al. Dietary milk-fat-globule membrane affects resistance to diarrheagenic Escherichia coli in healthy adults in a randomized, placebo-controlled, double-blind study. J Nutr. 2016;146:249–255.
19. Sarker SA, Sultana S, Pietroni M, et al. Safety of a bioactive polyphenol dietary supplement in pediatric subjects with acute diarrhoea. Int J Pediatr. 2015;2015:387159.
20. Noguera T, Wotring R, Melville CR, et al. Resolution of acute gastroenteritis symptoms in children and adults treated with a novel polyphenol-based prebiotic. World J Gastroenterol. 2014 Sep 14;20(34):12301–12307.
21. Dover A, Patel N, Park K. Rapid cessation of acute diarrhea using a novel solution of bioactive polyphenols: a randomized trial in Nicaraguan children. PeerJ. 2015;3:e969.
22. Thu HM, Myat TW, Win MM, et al. Chicken egg yolk antibodies (IgY) for prophylaxis and treatment of rotavirus diarrhea in human and animal neonates: a concise review. Kor J Food Sci Animl Resour. 2017;37:1–9.
23. Szajewska H. What are the indications for using probiotics in children? Arch Dis Child. 2016;101:398–403.
24. GBI Research. Gastrointestinal drugs market to Hit $48.4 billion [Internet]. Montville (NJ): Drug Development and Delivery; c2017; 2016 Oct 6. [cited 2017 May10]. Available from: http://www.drug-dev.com/Main/Back-Issues/Gastrointestinal-Drugs-Market-to-Hit-484-Billion––1198.aspx
25. Ja D, Hg G, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs [Internet]. Boston (MA): Tufts Center for the Study of Drug Development; c2017; 2014 Nov 18. [cited 2017 May10]. Available from: http://csdd.tufts.edu/news/complete_story/cost_study_press_event_webcast